Dinh Thanh, Lewis Casey
Department of Surgery, Division of Podiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA.
Department of Surgery, Division of Podiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA.
Clin Podiatr Med Surg. 2019 Oct;36(4):563-576. doi: 10.1016/j.cpm.2019.06.004. Epub 2019 Jul 29.
Amnion and chorion products show great promise and have real potential to be mainstays of treatment for chronic, nonhealing wounds. Although amniotic products do carry a cost, the decrease in time to healing, with the assumed subsequent decrease in complication and infection rates, should also be taken into consideration. These products, with their unique biologic potential and availability in the clinical setting, may prove to be beneficial in a vast array of podiatric surgical applications.
羊膜和绒毛膜产品显示出巨大的前景，并且确实有潜力成为慢性、不愈合伤口治疗的主要手段。尽管羊膜产品确实有成本，但愈合时间的缩短以及随之而来的并发症和感染率的降低也应予以考虑。这些产品具有独特的生物学潜力且可在临床环境中获取，可能在众多足病外科应用中被证明是有益的。
